血管閉合裝置市場：依產品類型、依接取方式、依孔徑、依最終用戶、按地區

血管閉合裝置市場規模預計在 2025 年達到 15.336 億美元，預計到 2032 年將達到 23.212 億美元，2025 年至 2032 年的複合年成長率為 6.1%。

血管閉合裝置有助於在心血管手術（例如血管造影術和血管成形術）後封閉動脈穿刺口。它們透過機械或生物方式促進自然凝血，從而幫助止血。隨著全球介入性心臟病學和放射學的發展，血管閉合裝置的全球使用量也不斷增加。與手動壓迫方法相比，血管閉合裝置可提高病患舒適度、縮短住院時間並降低併發症發生率，已成為血管通路管理的重要組成部分。

市場動態

由於人口變化和技術進步等多種因素的共同作用，全球血管閉合裝置市場正在經歷顯著成長。這種成長的主要原因是老年人口的增加，由於生理衰老，老年人更容易患心血管疾病。隨著老年人口的增加，心血管疾病的發生率也在上升，導致對診斷和治療程序後有效的血管閉合裝置的需求增加。同時，整個醫療保健產業明顯轉向微創手術 (MIS)。與傳統開放性手術相比，MIS 手術可降低感染風險、縮短住院時間並加速患者復原。血管閉合裝置在這些手術中起著關鍵作用，可快速止血、減少活動時間並提高患者的舒適度。

器械技術的進步也至關重要，它使器械的功效更高，並降低了術後併發症的風險。設計和材料的改進使產品能夠提供更好的密封性，並適應各種解剖結構和穿刺尺寸。然而，這些先進器械的高成本可能會成為其廣泛應用的障礙。某些醫療保健系統缺乏報銷機制，進一步加劇了這個問題，使患者難以獲得這些技術。現有的止血替代方法，例如手動按壓，通常會導致更長的恢復時間並增加併發症的風險。

該市場蘊含著巨大的機會，尤其是在新興經濟體，這些經濟體的醫療保健投資和醫療基礎建設正在不斷加強。新型器械的持續開發潛力巨大，例如由生物分解性材料製成的器械，這些器械常用於經導管主動脈瓣置換術(TAVR) 等複雜手術。總體而言，血管閉合器械的優勢，例如技術進步和對微創手術 (MIS) 的需求不斷成長，可能會繼續推動市場成長，儘管成本和報銷等挑戰仍然存在。

例如，2021 年 1 月，專注於提供創新醫療解決方案以促進更好患者治療效果的醫療技術公司 Haemonetics Corporation 簽署了最終協議，收購私人公司的血管閉合系統製造商 Cardiva Medical, Inc.。

研究的主要特點

• 本報告對全球血管閉合裝置市場進行了詳細分析，並以 2024 年為基準年，提供了預測期 2025-2032 的市場規模（百萬美元）和年複合成長率（CAGR%）。
• 它揭示了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球血管閉合裝置市場的主要企業概況。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球血管閉合裝置市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員將透過全球血管閉合裝置市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
• 人口老化加劇
• 血管成形術的激增
• 心血管疾病盛行率不斷上升
• 微創手術需求不斷成長
• 影響分析
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景

4. 全球血管閉合裝置市場（依產品類型），2020 年至 2032 年

• 介紹
• 被動血管閉合裝置
• 主動血管閉合裝置
• 外部閉合裝置

5. 全球血管閉合裝置市場（依訪問量分類），2020 年至 2032 年

• 介紹
• 股骨
• 半徑

6. 2020-2032 年全球血管閉合裝置市場（依孔徑）

• 介紹
• 小孔
• 遠射

7. 全球血管閉合裝置市場（依最終用戶分類），2020 年至 2032 年

• 介紹
• 醫院
• 門診手術中心
• 其他

8. 全球血管閉合裝置市場（按地區分類），2020-2032 年

• 介紹
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 東南亞國協
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 南非
  • 北非
  • 中部非洲

第9章 競爭態勢

• Abbott
• Cardiva Medical Inc.
• Terumo Corporation
• Johnson & Johnson Services Inc.
• B. Braun SE
• BIoTronik SE & Co. KG
• MicroPort Scientific Corporation
• ConforMIS, Inc.
• Medtronic
• Transluminal Technologies LLC
• Cardinal Health
• Teleflex Incorporated
• Vasorum Ltd.
• Tricol Biomedical
• Merit Medical Systems, Inc.
• Stryker

第 10 章 章節

• 調查方法
• 關於出版商

Vascular Closure Device Market is estimated to be valued at USD 1,533.6 Mn in 2025 and is expected to reach USD 2,321.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

Vascular closure devices help seal arterial punctures after a cardiovascular procedure such as angiography or angioplasty. They help stop bleeding at the puncture site by accelerating natural clotting through mechanical or biological means. The global usage of vascular closure devices has been increasing with growth in interventional cardiology and radiology procedures worldwide. Improved patient comfort, reduced hospital stay times, and lower complication rates compared to manual compression methods have made vascular closure devices an integral part of vascular access site management.

Market Dynamics

The global vascular closure device market is growing substantially, propelled by a confluence of factors ranging from demographic shifts to technological progress. A significant contributor to this growth is the rising geriatric population which is more susceptible to cardiovascular diseases due to physiological aging. As the elderly population grows, so does the incidence of cardiovascular conditions, thereby increasing the demand for effective vascular closure devices following diagnostic and therapeutic procedures. Simultaneously, a notable shift towards minimally invasive surgeries (MIS) across the healthcare sector. MIS procedures reduce the risk of infection, shorten hospital stays, and speed up patient recovery times compared to traditional open surgeries. Vascular closure devices play a key role in these procedures by providing rapid hemostasis, reducing time to ambulation, and enhancing patient comfort.

Advancements in device technology have also been pivotal, leading to devices that offer greater efficacy and a reduced risk of post-procedure complications. Enhanced designs and materials have yielded products with improved sealing capabilities and compatibility with various anatomies and puncture sizes. On the other side of the spectrum, the high costs associated with these advanced devices can act as a barrier to their widespread adoption. The lack of reimbursement in certain healthcare systems further exacerbates this issue, making it challenging for patients to access these technologies. While existing alternatives for achieving hemostasis, such as manual compression, exist, they often come with longer recovery times and elevated risks of complications, thereby providing an opening for the adoption of advanced vascular closure devices.

The market is ripe with opportunities, especially within emerging economies that are currently witnessing increased healthcare investments and enhancements to their healthcare infrastructure. The significant potential in the ongoing development of novel devices, including those made from biodegradable materials, commonly used in complex procedures like transcatheter aortic valve replacement (TAVR).Overall, while challenges like cost and reimbursement issues persist, the benefits of vascular closure devices, including the advancements in technology and rising demands for MIS, are likely to continue to drive market growth.

For instance, in January 2021, Haemonetics Corporation, a medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, entered into a definitive agreement to acquire privately-held Cardiva Medical, Inc., a manufacturer of vascular closure systems.

Key features of the study

• This report provides in-depth analysis of the global vascular closure device market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global vascular closure device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbott, Cardiva Medical Inc., Terumo Corporation, Johnson & Johnson Services Inc., B. Braun SE, Biotronik SE & Co. KG, MicroPort Scientific Corporation, ConforMIS, Inc., Medtronic, Transluminal Technologies LLC, Cardinal Health, Teleflex Incorporated, Vasorum Ltd., Tricol Biomedical, Merit Medical Systems, Inc., Stryker
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global vascular closure device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vascular closure device market.

Market Segmentation

• By Product Type
  • Passive Vascular Closure Devices
  • Active Vascular Closure Devices
  • External Hemostatic Devices
• By Access
  • Femoral
  • Radial
• By Hole Size
  • Small Hole
  • Large Hole
• By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Others
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Top companies in Global Vascular Closure Device Market
  • Abbott
  • Cardiva Medical Inc.
  • Terumo Corporation
  • Johnson & Johnson Services Inc.
  • B. Braun SE
  • Biotronik SE & Co. KG
  • MicroPort Scientific Corporation
  • ConforMIS, Inc.
  • Medtronic
  • Transluminal Technologies LLC
  • Cardinal Health
  • Teleflex Incorporated
  • Vasorum Ltd.
  • Tricol Biomedical
  • Merit Medical Systems, Inc.
  • Stryker

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Vascular Closure Device Market, By Product Type
  • Vascular Closure Device Market, By Access
  • Vascular Closure Device Market, By Hole Size
  • Vascular Closure Device Market, By End User
  • Vascular Closure Device Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
• Rising geriatric population
• The proliferation of angioplasty procedures
• The increasing prevalence of cardiovascular diseases incidence
• Increasing demand for minimally invasive surgeries
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Vascular Closure Device Market, By Product Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Passive Vascular Closure Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• Active Vascular Closure Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• External Hemostatic Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)

5. Global Vascular Closure Device Market, By Access, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Femoral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• Radial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)

6. Global Vascular Closure Device Market, By Hole Size, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Small Hole
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• Large Hole
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)

7. Global Vascular Closure Device Market, By End User, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• Ambulatory Surgery Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)

8. Global Vascular Closure Device Market, By Region, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(USD Mn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Abbott
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cardiva Medical Inc.
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Terumo Corporation
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Johnson & Johnson Services Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• B. Braun SE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Biotronik SE & Co. KG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• MicroPort Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• ConforMIS, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Transluminal Technologies LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Teleflex Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vasorum Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Tricol Biomedical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Merit Medical Systems, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Stryker
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us